Home
About
Strategy
Investments
News
Contact
Home
About
Strategy
Investments
News
Contact
NEWS
A selection of articles about companies we have supported
2023
|
2022
|
2021
|
2020
|
2019
November 15, 2023
Cytovale Secures $84 Million Series C to Advance Commercialization of Transformative Sepsis Diagnostic Tool
Read more
OCTOBER 16, 2023
Modifi Bio Raises Additional $4.3 Million in Seed Funding
Read more
OCTOBER 4, 2023
Dimension Inx Announces First Surgical Cases Utilizing CMFlex™ Synthetic Bone Graft
Read more
August 1, 2023
Cytovale Announces Commercial Launch of IntelliSep® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments
Read more
May 16, 2023
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors
Read more
february 1, 2023
Dimension Inx Receives U.S. FDA 510(k) for CMFlex™ and Raises $12M Series A to Commercialize New Generation of Regenerative Therapeutics
Read more
january 18, 2023
FDA Clears Cytovale’s IntelliSep Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools
Read more
2023
|
2022
|
2021
|
2020
|
2019